SVG
Cell and Gene Therapy
Overview
Cell and gene therapies are transforming how we can treat and potentially cure disease. In response to a rapidly growing pipeline and the hope these therapies offer, FasterCures convenes roundtables and discussions to bring to light the unique regulatory and access considerations posed by cell and gene therapies.
Related Videos
Accelerating Access to Lifesaving Treatments and Cures: Insights from FDA's Expedited Review Programs
This session discusses the successes of the accelerated approval pathway for the patient community, reform efforts underway, and how stakeholders are balancing the utility of expedited approval programs with concerns raised about their effectiveness.
Time=Lives and Value-Based Payment Models: Are They Working?
Value-based payment has long been viewed as a key approach to facilitating access while ensuring accountability for costs and quality. But when it comes to transformative technologies, such as gene therapies that carry price tags much higher than conventional therapies, are value-based payment models still the right approach?
How Should We Value a Cure?
Although we've come a long way, much work remains to be done to ensure that determinations of the value of cell and gene therapies integrate the perspectives of those they are intended to help: Patients.
Watch More Related Videos
Browse more event sessions and webinars on cell and gene therapies and accelerating innovation in this space in the content hub.